1. Apoptag Plus. In Situ Apoptosis Detection Kit. Peroxidase Catalog # s7101-Kit. Oncor Inc. 1995. 2. Vazquez AM, Perez A, Hernandez AM, Macias A, Alfonso M, Bombino G,Perez R. (1998) Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody. Hybridoma 17(6):527-34. 3. Alfonso M, Diaz A, Hernandez AM, Perez A, Rodriguez E, Bitton R, Perez R,Vazquez AM. (2002) An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients. J Immunol 168(5):2523-9. 4. Diaz A, Alfonso M, Alonso R, Saurez G, Troche M, Catala M, Diaz RM, Perez R,Vazquez AM. (2003) Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides. Clin Immunol 107(2):80-9. 5. Vazquez AM, Gabri MR, Hernandez AM, Alonso DF, Beausoleil I, Gomez DE,Perez R. (2000) Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides. Oncol Rep 7(4):751-6. 6. Kedar D, Baker CH, Killion JJ, Dinney CP,Fidler IJ. (2002) Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 8(11):3592-600. 7. Bruns CJ, Harbison MT, Davis DW, Portera CA, Tsan R, McConkey DJ, Evans DB, Abbruzzese JL, Hicklin DJ,Radinsky R. (2000) Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clin Cancer Res 6(5):1936-48. 8. Jung Y.D, Mansfield P.F, Akagi M, Takeda A, Liu W, Bucana C.D, Hiclin D.J, Ellis L.M. (2002). Effects of combination anti-vascular endothelial factor receptor and anti-epidermal growth factor therapy on the growth of gastric cancer in a nude mouse model. European Journal of cancer 38,1133-40.
|